Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiaoaiping pills for intestinal immunity and barrier function in colorectal cancer
ChiCTR2100052382Phase 4Not yet recruiting
- Sponsor
- Tianjin Union Medical Center
- Start
- Oct 2021
- Countries
- 1
01
Overview
Phase 4, randomised trial in colorectal cancer (CRC) comparing Treatment group (Xiaoaiping pill) with Control group (placebo) (2 arms). Primary endpoints: Gut microbiota composition, Lymphocyte subpopulations and 2 more. Planned start Oct 2021; status: not yet recruiting.
02
Drugs
xiaoaiping
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR2100052382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052382.